Mostafa Ronaghi

Mostafa Ronaghi

Mostafa Ronaghi (Persian: مصطفی رونقی; born 1968[not verified in body]) is an Iranian molecular biologist, specializing in DNA sequencing methodology. As of 2008, he was the Chief Technology Officer and Senior Vice President at Illumina.[independent source needed]

Early life and education

Mostafa Ronaghi was born in 1968.[where?][citation needed] He earned his Ph.D. from the Royal Institute of Technology in Sweden in 1998.[citation needed]

Career

Ronaghi was a principal investigator and Senior Research Associate at the Stanford Genome Technology Center at Stanford University, prior to working at Illumina),[when?] where he focused on developing analytical techniques for molecular diagnostics.[citation needed] He is principal investigator for several grants including grants from the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health for the development of array-based pyrosequencing.[better source needed]

In 1998, Ronaghi, Pål Nyren, and Mathias Uhlen described a solution-based variant of the pyrosequencing technology, and co-founded Pyrosequencing AB (renamed to Biotage in 2003).[citation needed] He co-invented molecular inversion probe assays,[clarification needed][citation needed] and co-founded ParAllele BioScience to develop this multiplexed technology for genetic testing.[citation needed] ParAllele was acquired by Affymetrix in May 2005.[citation needed]

In 2005, Ronaghi co-founded NextBio, a search engine for life science data.[verification needed] As of 2008, he was serving as the Chief Technology Officer and Senior Vice President at Illumina.[independent source needed]

NextBio was acquired by Illumina in 2013. He also serves on the board of directors of IntegenX and Aurora Biofuels. In 2008, Ronaghi and Helmy Eltoukhy co-founded Avantome, a DNA sequencing company that was acquired by Illumina in July 2008.